Topical Ingenol Mebutate Versus 5% 5-fluorouracil Versus 5% Imiquimod Versus Photodynamic Therapy in Treatment of Actinic Keratosis: a Multi-centre Randomized Efficacy and Cost-effectiveness Study
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Fluorouracil (Primary) ; Imiquimod (Primary) ; Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 27 Oct 2017 Planned End Date changed from 1 Jan 2018 to 1 Dec 2018.
- 27 Oct 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jul 2018.
- 27 Oct 2017 Status changed from recruiting to active, no longer recruiting.